NCT05050617 Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
| NCT ID | NCT05050617 |
| Status | Recruiting |
| Phase | — |
| Sponsor | WellSpan Health |
| Condition | Pulmonary Embolism |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2021-09-09 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2021-09-09 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.
Eligibility Criteria
Inclusion Criteria: * Age \>= 18 years of age * ED diagnosis of acute pulmonary embolism with identification on CT imaging Exclusion Criteria: * Age \<18 years of age * Inability to provide informed consent * Incarceration * Current PE previously diagnosed prior to index ED visit
Contact & Investigator
Brent A Becker, MD
PRINCIPAL INVESTIGATOR
WellSpan Health
Frequently Asked Questions
Who can join the NCT05050617 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Embolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05050617 currently recruiting?
Yes, NCT05050617 is actively recruiting participants. Contact the research team at bbecker2@wellspan.org for enrollment information.
Where is the NCT05050617 trial being conducted?
This trial is being conducted at York, United States.
Who is sponsoring the NCT05050617 clinical trial?
NCT05050617 is sponsored by WellSpan Health. The principal investigator is Brent A Becker, MD at WellSpan Health. The trial plans to enroll 250 participants.